Quantcast

Latest Ore Pharmaceuticals Inc. Stories

2008-10-01 06:00:48

Ore Pharmaceuticals Inc. (NASDAQ: ORXE) announced today that it has initiated dosing subjects with GL1001, the Company's lead drug candidate, in a multiple ascending dose clinical trial.

2008-08-06 18:00:38

Ore Pharmaceuticals Inc. (NASDAQ:ORXE) announced today that it has acquired from Roche the exclusive development rights for the clinical-stage compound romazarit.

2008-07-31 06:00:55

Ore Pharmaceuticals Inc. (NASDAQ:ORXE) announced today that it has acquired from Roche the clinical-stage compound tiapamil.

2008-07-01 06:00:12

Ore Pharmaceuticals Inc. (NASDAQ:ORXE) announced today that it has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for GL1001, the first clinical-stage inhibitor of the ACE2 enzyme.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.